13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • South Australia - Prostate

    Every day researchers work towards finding new breakthroughs in cancer. Clinical trials play a pivotal role in bringing that defeat closer.

    Clinical trials test promising new treatments on people to see if they are better than existing cancer treatments. The trial process is long starting many years before an actual treatment can be used.

    By joining a clinical trial you are helping to create new breakthroughs in cancer research. Hundreds of thousands of people all over the world have taken part in clinical trials that have lead to safer and more effective treatments for many cancers.

    It is important to note that not all cancer patients are eligible to take part in clinical trials and there are not clinical trials for all types of cancer.

    You may decide to join a clinical trial because:

    • The treatment you receive will be at least the best available for your illness.
    • Your health may improve because of the treatment you receive.
    • You may receive a treatment you would not otherwise have access to.
    • Your health will be carefully checked by the treatment team running the trial.
    • You will be part of the worldwide effort to improve cancer treatment.

    For more information on clinical trials please click here.

    Clinical trial managers:

    If you would like information regarding any of the below clinical trials, please contact the appropriate Clinical trials manager:

    Ashford Cancer Centre: Helen Daykin, +61 8 8292 2240

    Flinders Medical Centre: Alex Scott-Hoy, +61 8 8204 4830

    The Queen Elizabeth:  Sue Yeend, +61 8 8222 6148

    Lyell McEwin Hospitals: Julie Rowe or Rohit Joshi +61 8 8282 0833

    Royal Adelaide Hospital: Anne Milton, +61 8 7074 2342

    Current clinical trials for prostate cancer

    Status Description Organisation
    Recruiting 17777 A Randomized, double –blind, placebo –controlled Phase III study of ODM-201 versus placebo in addition to standard androgen deprivation therapy and docetaxel in patients with metastatic hormone-sensitive prostate cancer. BAY 1841788/17777 Royal Adelaide Hospital
    Not yet recruiting 3194007 ARAMIS A Multinational, Randomised, Double-Blind, Placebo-Controlled, Phase III Efficacy and Safety Study of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer. Ashford Cancer Centre Research
    Recruiting 64091742PCR2001 (GALAHAD) A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration- Resistant Prostate Cancer and DNA-Repair Anomalies. Ashford Cancer Centre Research
    Recruiting ANZUP1303 Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer Ashford Cancer Centre Research
    Not yet Recruiting ARCHES astellas prostate. A Multinational, Phase 3, Randomized, Double-blind, Placebocontrolled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Flinders Medical Centre
    Recruiting CO39303 - A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Testing Ipatasertib Plus Abiraterone Plus Prednisolone/ Prednisolone, Relative To Placebo Plus Abiraterone Plus Prednisolone / Prednisolone In Adult Male Patients With Asymptomatic Or Midly Symptomatic, Previously Untreated, Metastatic-Castrate Resistant Prostate Cancer. Ashford Cancer Centre Research
    Recruiting CO39385 - Imbassador 250: A phase III, multicenter, randomized study of atezolizumab (anti-PD-L1 antibody) in combination with enzalutamide versus enzalutamide alone in patients with metatstatic castration-resistant prostate cancer after failure of an androgen synthesis inhibitor and failure of, ineligibility for, or refusal of a taxane regimen. Ashford Cancer Centre Research
    Recruiting EMBARK Phase 3, Randomized, Efficacy and Safety Study of Enzalutamide Plus Leuprolide, Enzalutamide Monotherapy, and Placebo Plus Leuprolide in Men With High-Risk Nonmetastatic Prostate Cancer Progressing After Definitive Therapy Royal Adelaide Hospital
    Recruiting ENZARAD - Randomised phase 3 trial of radiation plus androgen deprivation therapy with or without enzalutamide for high risk, clinically localized, prostate cancer Flinders Medical Centre
    Recruiting A Phase III, open-label, randomized study to assess the efficacy and safety of Olararib (Lynparza) vs Enzalutamide or Abiraterone Acetate in men with MCRPC who have failed prior treatment with a new hormonal agent and have homologous recombination repair gene mutations Royal Adelaide Hospital
    Not Yet Recruiting proPSMA A prospective randomised multi-centre study of the impact of Ga-68 PSMA-PET/CT imaging for staging high risk prostate cancer prior to curative-intent surgery or radiotherapy Royal Adelaide Hospital
    Not yet Recruiting TDM in Prostate Cancer Therapeutic Drug Monitoring of Docetaxel during treatment for men with Prostate Cancer Flinders Medical Centre
    Recruiting VIPER A Phase I trial of Sodium Valproate/MetformIn Combination as neoadjuvant therapy for ProstatE canceR – VIPER 1 trial Flinders Medical Centre

    Today at Cancer Council SA

  • Do you have a cancer question?

    Do you have a cancer question?

    Cancer causes questions. Call us for the answers.

  • Donate in lieu of flowers

    Donate in lieu of flowers

    Remembering loved ones by ensuring no one goes through cancer alone.

  • Fundraising events

    Fundraising events

    We have a wide range of exciting events that give you the opportunity to support our vision of a cancer free future in a fun, easy yet symbolic way.

  • Healthy Living after Cancer

    Healthy Living after Cancer

    Getting back to a healthy lifestyle after cancer is one of the most important things you can do for your health. Find out about our Healthy Living after Cancer program.

  • Heard something about cancer and not sure if it's true?

    Heard something about cancer and not sure if it's true?

    Get all the evidence based answers to your cancer questions here.

  • Join the conversation

    Join the conversation

    Follow us on Facebook to stay up to date with the latest community events and news.

  • More than a gift, it's hope for the future

    More than a gift, it's hope for the future

    Including a bequest to Cancer Council SA in your will is not an alternative to looking after your loved ones, it’s part of it. Find out more.

  • Quitline

    Quitline

    Quitline is a government-funded service operated by Cancer Council SA, with the sole goal of providing the support, strategies and information to empower individuals to quit smoking.